Cardiovascular Research, ISSN 0008-6363, 04/2017, Volume 113, Issue 5, pp. 431 - 433
Journal Article
Circulation: Cardiovascular Genetics, ISSN 1942-325X, 10/2010, Volume 3, Issue 5, pp. 484 - 488
Heart failure | Myocardial infarction | Biomarker | Exosomes | MicroRNAs | microRNAs | heart failure | CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | myocardial infarction | HEART-FAILURE | RNAS | MICROVESICLES | SERUM | biomarker | MICROPARTICLES | PLASMA | exosomes | GENETICS & HEREDITY | ACUTE MYOCARDIAL-INFARCTION | Paracrine Communication | Humans | Risk Factors | Cardiovascular Diseases - blood | MicroRNAs - blood | MicroRNAs - genetics | Biomarkers - blood | Cardiovascular Diseases - genetics
Journal Article
Plant Breeding, ISSN 0179-9541, 08/2013, Volume 132, Issue 4, pp. 401 - 406
Crosses were performed to introgress genes for productivity and other desirable traits from ricebean (Vigna umbellata) into black gram (Vigna mungo)....
Vigna | productivity | disease resistance | interspecific hybridization | introgression | Productivity | Disease resistance | Introgression | Interspecific hybridization | AGRONOMY | CHICKPEA | YIELD | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | YELLOW MOSAIC-VIRUS | RESISTANCE | PLANT SCIENCES
Vigna | productivity | disease resistance | interspecific hybridization | introgression | Productivity | Disease resistance | Introgression | Interspecific hybridization | AGRONOMY | CHICKPEA | YIELD | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | YELLOW MOSAIC-VIRUS | RESISTANCE | PLANT SCIENCES
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0139305
Background and Aim Patients with primary sclerosing cholangitis (PSC) are at high risk for the development of cholangiocarcinoma (CC). Analysis of micro...
HEPATOCELLULAR-CARCINOMA | INVASION | MANAGEMENT | METASTASIS | CANCER CELLS | MULTIDISCIPLINARY SCIENCES | LIVER-DISEASE | CONTRIBUTES | EXPRESSION | PROGRESSION | MIR-194 | Care and treatment | MicroRNA | Research | Risk factors | Cholangitis | Liver diseases | Laboratories | MiRNA | Life assessment | Kinases | Gene expression | Medical diagnosis | Patients | Medical schools | Polymerase chain reaction | Hepatitis | MicroRNAs | Hepatology | Gastroenterology | Cell cycle | Diagnostic systems | Endoscopy | Arrays | Cholangiocarcinoma | Endocrinology | Cancer | Bile
HEPATOCELLULAR-CARCINOMA | INVASION | MANAGEMENT | METASTASIS | CANCER CELLS | MULTIDISCIPLINARY SCIENCES | LIVER-DISEASE | CONTRIBUTES | EXPRESSION | PROGRESSION | MIR-194 | Care and treatment | MicroRNA | Research | Risk factors | Cholangitis | Liver diseases | Laboratories | MiRNA | Life assessment | Kinases | Gene expression | Medical diagnosis | Patients | Medical schools | Polymerase chain reaction | Hepatitis | MicroRNAs | Hepatology | Gastroenterology | Cell cycle | Diagnostic systems | Endoscopy | Arrays | Cholangiocarcinoma | Endocrinology | Cancer | Bile
Journal Article
5.
Full Text
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Nature Communications, ISSN 2041-1723, 2012, Volume 3, Issue 1, p. 1078
Pathological growth of cardiomyocytes (hypertrophy) is a major determinant for the development of heart failure, one of the leading medical causes of mortality...
ATROPHY | MOUSE MAMMARY-GLAND | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | IN-VIVO | CONDUCTION | MICE | MICRORNAS | TARGETED DELETION | STRESS | EXPRESSION | Oligonucleotides - genetics | Cells, Cultured | Rats | Male | Mice, Transgenic | Reverse Transcriptase Polymerase Chain Reaction | Animals | Calcineurin - genetics | Myocytes, Cardiac - metabolism | Mice | MicroRNAs - genetics | Autophagy - genetics | Cardiomegaly - genetics
ATROPHY | MOUSE MAMMARY-GLAND | MULTIDISCIPLINARY SCIENCES | HEART-FAILURE | IN-VIVO | CONDUCTION | MICE | MICRORNAS | TARGETED DELETION | STRESS | EXPRESSION | Oligonucleotides - genetics | Cells, Cultured | Rats | Male | Mice, Transgenic | Reverse Transcriptase Polymerase Chain Reaction | Animals | Calcineurin - genetics | Myocytes, Cardiac - metabolism | Mice | MicroRNAs - genetics | Autophagy - genetics | Cardiomegaly - genetics
Journal Article
Biologia, ISSN 0006-3088, 6/2015, Volume 70, Issue 6, pp. 846 - 852
B-cell lymphoma 2 (Bcl-2) and heat shock protein (HSP) families are implicated in various processes of carcinogenesis, owing to their role in regulation of...
Life Sciences | canine mammary tumor | HSP70 | Life Sciences, general | Microbiology | HSP90-β | Zoology | apoptosis-associated genes | Plant Sciences | Cell Biology | Bcl-2 family | PROGNOSTIC FACTORS | HEAT-SHOCK-PROTEIN-70 | NEOPLASMS | HSP90-beta | CLASSIFICATION | NEGATIVE BREAST-CANCER | HEAT-SHOCK PROTEINS | PROSTATE-CANCER | BIOLOGY | STRESS | Breast tumors | Dogs | Genetic aspects | Gene expression | Health aspects | Apoptosis | Diseases
Life Sciences | canine mammary tumor | HSP70 | Life Sciences, general | Microbiology | HSP90-β | Zoology | apoptosis-associated genes | Plant Sciences | Cell Biology | Bcl-2 family | PROGNOSTIC FACTORS | HEAT-SHOCK-PROTEIN-70 | NEOPLASMS | HSP90-beta | CLASSIFICATION | NEGATIVE BREAST-CANCER | HEAT-SHOCK PROTEINS | PROSTATE-CANCER | BIOLOGY | STRESS | Breast tumors | Dogs | Genetic aspects | Gene expression | Health aspects | Apoptosis | Diseases
Journal Article
Circulation Research, ISSN 0009-7330, 07/2010, Volume 107, Issue 1, pp. 138 - 143
RATIONALE:The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA) is increased in patients with coronary artery disease and may...
Oxidative stress | ADMA | Coronary artery disease | MicroRNAs | Endothelial progenitor cells | Arginine - physiology | Angiogenesis Inhibitors - physiology | Coronary Artery Disease - metabolism | Humans | Gene Expression Regulation - physiology | MicroRNAs - biosynthesis | Stem Cells - cytology | Stem Cells - metabolism | Arginine - analogs & derivatives | Neovascularization, Pathologic - pathology | Coronary Artery Disease - genetics | Coronary Artery Disease - pathology | Stem Cells - pathology | Neovascularization, Pathologic - genetics | Neovascularization, Pathologic - prevention & control | MicroRNAs - genetics | MicroRNAs - physiology
Oxidative stress | ADMA | Coronary artery disease | MicroRNAs | Endothelial progenitor cells | Arginine - physiology | Angiogenesis Inhibitors - physiology | Coronary Artery Disease - metabolism | Humans | Gene Expression Regulation - physiology | MicroRNAs - biosynthesis | Stem Cells - cytology | Stem Cells - metabolism | Arginine - analogs & derivatives | Neovascularization, Pathologic - pathology | Coronary Artery Disease - genetics | Coronary Artery Disease - pathology | Stem Cells - pathology | Neovascularization, Pathologic - genetics | Neovascularization, Pathologic - prevention & control | MicroRNAs - genetics | MicroRNAs - physiology
Journal Article
8.
Full Text
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 2011, Volume 51, Issue 5, pp. 872 - 875
Abstract Circulating microRNAs may have diagnostic potential in acute coronary syndrome (ACS). Previous studies, however, were based on low patient numbers and...
Cardiovascular | Myocardial infarction | Biomarker | Prognosis | Acute coronary syndrome | MicroRNAs | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CELL BIOLOGY | BIOMARKERS | HEART | PLASMA | CARDIOVASCULAR-DISEASE | EXPRESSION | Myocardial Infarction - blood | Myocardial Infarction - genetics | Predictive Value of Tests | Myocardial Infarction - mortality | Prospective Studies | Follow-Up Studies | Humans | Acute Coronary Syndrome - mortality | Angina, Unstable - diagnosis | Male | Troponin T - blood | Female | Myocardial Infarction - diagnosis | Troponin T - genetics | Myocytes, Cardiac - cytology | Risk Factors | Angina, Unstable - mortality | Survival Rate | Biomarkers - blood | Reverse Transcriptase Polymerase Chain Reaction | Acute Coronary Syndrome - blood | Regression Analysis | Angina, Unstable - genetics | Angina, Unstable - blood | Acute Coronary Syndrome - diagnosis | Myocytes, Cardiac - metabolism | MicroRNAs - blood | MicroRNAs - genetics | Acute Coronary Syndrome - genetics | Germany | Coronary heart disease | Analysis | Diagnosis
Cardiovascular | Myocardial infarction | Biomarker | Prognosis | Acute coronary syndrome | MicroRNAs | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | CELL BIOLOGY | BIOMARKERS | HEART | PLASMA | CARDIOVASCULAR-DISEASE | EXPRESSION | Myocardial Infarction - blood | Myocardial Infarction - genetics | Predictive Value of Tests | Myocardial Infarction - mortality | Prospective Studies | Follow-Up Studies | Humans | Acute Coronary Syndrome - mortality | Angina, Unstable - diagnosis | Male | Troponin T - blood | Female | Myocardial Infarction - diagnosis | Troponin T - genetics | Myocytes, Cardiac - cytology | Risk Factors | Angina, Unstable - mortality | Survival Rate | Biomarkers - blood | Reverse Transcriptase Polymerase Chain Reaction | Acute Coronary Syndrome - blood | Regression Analysis | Angina, Unstable - genetics | Angina, Unstable - blood | Acute Coronary Syndrome - diagnosis | Myocytes, Cardiac - metabolism | MicroRNAs - blood | MicroRNAs - genetics | Acute Coronary Syndrome - genetics | Germany | Coronary heart disease | Analysis | Diagnosis
Journal Article
9.
Full Text
Circulating miR-210 Predicts Survival in Critically Ill Patients with Acute Kidney Injury
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 07/2011, Volume 6, Issue 7, pp. 1540 - 1546
Background and objectives MicroRNAs (miRNAs) are small ribonucleotides regulating gene expression. MicroRNAs are present in the blood in a remarkably stable...
BIOMARKERS | MYOCARDIAL-INFARCTION | INTENSIVE-CARE-UNIT | EXTENDED DIALYSIS | HEART-FAILURE | DISEASE | UROLOGY & NEPHROLOGY | ACUTE-RENAL-FAILURE | MICRORNAS | ANGIOPOIETIN-2 | OUTCOMES | Up-Regulation | Humans | Middle Aged | Critical Illness | Male | Acute Kidney Injury - genetics | Case-Control Studies | Time Factors | Polymerase Chain Reaction | Adult | Female | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Renal Replacement Therapy | Survival Rate | Treatment Outcome | Genetic Markers | Chi-Square Distribution | Acute Kidney Injury - mortality | Analysis of Variance | Acute Kidney Injury - diagnosis | Acute Kidney Injury - therapy | MicroRNAs - blood | Germany
BIOMARKERS | MYOCARDIAL-INFARCTION | INTENSIVE-CARE-UNIT | EXTENDED DIALYSIS | HEART-FAILURE | DISEASE | UROLOGY & NEPHROLOGY | ACUTE-RENAL-FAILURE | MICRORNAS | ANGIOPOIETIN-2 | OUTCOMES | Up-Regulation | Humans | Middle Aged | Critical Illness | Male | Acute Kidney Injury - genetics | Case-Control Studies | Time Factors | Polymerase Chain Reaction | Adult | Female | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Renal Replacement Therapy | Survival Rate | Treatment Outcome | Genetic Markers | Chi-Square Distribution | Acute Kidney Injury - mortality | Analysis of Variance | Acute Kidney Injury - diagnosis | Acute Kidney Injury - therapy | MicroRNAs - blood | Germany
Journal Article
Basic Research in Cardiology, ISSN 0300-8428, 9/2012, Volume 107, Issue 5, pp. 1 - 12
Atrial fibrosis is important for the pathogenesis of atrial fibrillation (AF) but the underlying signal transduction is incompletely understood. We therefore...
MicroRNA | Medicine & Public Health | Atrial fibrosis | Atrial fibrillation | miR-21 | Cardiology | Lysyl oxidase | MiR-21 | FIBRILLATION | SMALL SILENCING RNAS | CARDIAC & CARDIOVASCULAR SYSTEMS | REDOX STATE | HEART-FAILURE | ANGIOTENSIN-II | MICRORNAS | TISSUE GROWTH-FACTOR | MICE | RAC1
MicroRNA | Medicine & Public Health | Atrial fibrosis | Atrial fibrillation | miR-21 | Cardiology | Lysyl oxidase | MiR-21 | FIBRILLATION | SMALL SILENCING RNAS | CARDIAC & CARDIOVASCULAR SYSTEMS | REDOX STATE | HEART-FAILURE | ANGIOTENSIN-II | MICRORNAS | TISSUE GROWTH-FACTOR | MICE | RAC1
Journal Article
11.
Full Text
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
European Journal of Heart Failure, ISSN 1388-9842, 04/2015, Volume 17, Issue 4, pp. 405 - 415
Aims Differentiation of heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction independent of echocardiography is challenging in the...
Heart failure | Biomarker | MicroRNA | Diagnosis | Natriuretic peptide | Ejection fraction | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | FOLLOW-UP | EUROPEAN-SOCIETY | BIOMARKERS | CARDIAC-HYPERTROPHY | COLLABORATION | ECHOCARDIOGRAPHIC HEART | DYSFUNCTION | ASSOCIATION | EXPRESSION | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Biomarkers - blood | Natriuretic Peptides | Heart Ventricles - physiopathology | Aged, 80 and over | Female | Aged | Heart Failure - diagnosis | MicroRNAs - blood | Ventricular Dysfunction - physiopathology | Cohort Studies
Heart failure | Biomarker | MicroRNA | Diagnosis | Natriuretic peptide | Ejection fraction | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | FOLLOW-UP | EUROPEAN-SOCIETY | BIOMARKERS | CARDIAC-HYPERTROPHY | COLLABORATION | ECHOCARDIOGRAPHIC HEART | DYSFUNCTION | ASSOCIATION | EXPRESSION | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Biomarkers - blood | Natriuretic Peptides | Heart Ventricles - physiopathology | Aged, 80 and over | Female | Aged | Heart Failure - diagnosis | MicroRNAs - blood | Ventricular Dysfunction - physiopathology | Cohort Studies
Journal Article
Clinical Chemistry, ISSN 0009-9147, 01/2015, Volume 61, Issue 1, pp. 191 - 201
BACKGROUND: Long noncoding RNAs (lncRNAs) are novel intracellular noncoding ribonucleotides regulating gene expression. Intriguingly, these RNA transcripts are...
PROSTATE | INTENSIVE-CARE-UNIT | EXTENDED DIALYSIS | DISEASE | TRANSCRIPTION | ACUTE-RENAL-FAILURE | MICRORNAS | OUTCOMES | MEDICAL LABORATORY TECHNOLOGY | CANCER | RNA sequencing | Genetic aspects | Mortality | Methods | Acute renal failure | Proteins | Studies | Urine | Plasma | Intensive care | Heart attacks | Consent | Biomarkers | Genomes | Kidney diseases
PROSTATE | INTENSIVE-CARE-UNIT | EXTENDED DIALYSIS | DISEASE | TRANSCRIPTION | ACUTE-RENAL-FAILURE | MICRORNAS | OUTCOMES | MEDICAL LABORATORY TECHNOLOGY | CANCER | RNA sequencing | Genetic aspects | Mortality | Methods | Acute renal failure | Proteins | Studies | Urine | Plasma | Intensive care | Heart attacks | Consent | Biomarkers | Genomes | Kidney diseases
Journal Article
Circulation, ISSN 0009-7322, 2011, Volume 124, Issue 6, pp. 720 - 730
BACKGROUND: Myocardial infarction leads to cardiac remodeling and development of heart failure. Insufficient myocardial capillary density after myocardial...
microRNAs | heart failure | antagomir | angiogenesis | gene expression | myocardial infarction | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | ZEBRAFISH | HEART-FAILURE | DOWN-REGULATION | KAPPA-B | HUMAN ENDOTHELIAL-CELLS | CONTROLS ANGIOGENESIS | CARDIAC-HYPERTROPHY | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | NEOVASCULARIZATION | HEMATOLOGY | Myocardial Infarction - genetics | Neovascularization, Physiologic - drug effects | MicroRNAs - antagonists & inhibitors | Capillaries - pathology | Apoptosis - drug effects | Male | Gene Expression Profiling | Zebrafish - embryology | Cell Hypoxia | Oligoribonucleotides - pharmacology | Heme Oxygenase-1 - genetics | GATA2 Transcription Factor - biosynthesis | Ventricular Remodeling | Laminin | RNA Interference | Myocardial Infarction - physiopathology | Drug Evaluation, Preclinical | Spheroids, Cellular | Heart Failure - etiology | GATA2 Transcription Factor - genetics | Cells, Cultured - drug effects | Zebrafish Proteins - biosynthesis | Heme Oxygenase-1 - biosynthesis | Proteoglycans | p21-Activated Kinases - genetics | Endothelial Cells - metabolism | Neovascularization, Physiologic - genetics | Mice, Inbred C57BL | RNA, Small Interfering - pharmacology | p21-Activated Kinases - biosynthesis | Arterioles - pathology | Myocardial Infarction - complications | Animals | RNA, Small Interfering - therapeutic use | Collagen | Cells, Cultured - metabolism | Mice | MicroRNAs - genetics | MicroRNAs - physiology | Zebrafish Proteins - genetics | Endothelial Cells - pathology | Drug Combinations | Heart failure | MicroRNA | Patient outcomes | Physiological aspects | Development and progression | Genetic aspects | Neovascularization | Research | Heart attack
microRNAs | heart failure | antagomir | angiogenesis | gene expression | myocardial infarction | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | ZEBRAFISH | HEART-FAILURE | DOWN-REGULATION | KAPPA-B | HUMAN ENDOTHELIAL-CELLS | CONTROLS ANGIOGENESIS | CARDIAC-HYPERTROPHY | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | NEOVASCULARIZATION | HEMATOLOGY | Myocardial Infarction - genetics | Neovascularization, Physiologic - drug effects | MicroRNAs - antagonists & inhibitors | Capillaries - pathology | Apoptosis - drug effects | Male | Gene Expression Profiling | Zebrafish - embryology | Cell Hypoxia | Oligoribonucleotides - pharmacology | Heme Oxygenase-1 - genetics | GATA2 Transcription Factor - biosynthesis | Ventricular Remodeling | Laminin | RNA Interference | Myocardial Infarction - physiopathology | Drug Evaluation, Preclinical | Spheroids, Cellular | Heart Failure - etiology | GATA2 Transcription Factor - genetics | Cells, Cultured - drug effects | Zebrafish Proteins - biosynthesis | Heme Oxygenase-1 - biosynthesis | Proteoglycans | p21-Activated Kinases - genetics | Endothelial Cells - metabolism | Neovascularization, Physiologic - genetics | Mice, Inbred C57BL | RNA, Small Interfering - pharmacology | p21-Activated Kinases - biosynthesis | Arterioles - pathology | Myocardial Infarction - complications | Animals | RNA, Small Interfering - therapeutic use | Collagen | Cells, Cultured - metabolism | Mice | MicroRNAs - genetics | MicroRNAs - physiology | Zebrafish Proteins - genetics | Endothelial Cells - pathology | Drug Combinations | Heart failure | MicroRNA | Patient outcomes | Physiological aspects | Development and progression | Genetic aspects | Neovascularization | Research | Heart attack
Journal Article
European Heart Journal, ISSN 0195-668X, 08/2015, Volume 36, Issue 32, pp. 2184 - 2196
Aims Osteopontin (OPN) is a multifunctional cytokine critically involved in cardiac fibrosis. However, the underlying mechanisms are unresolved. Non-coding...
Osteopontin | Cardiac fibrosis | microRNA | miR-21 | Angiotensin II | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANISM | HEART-FAILURE | PROMATRIX METALLOPROTEINASE-9 ACTIVATION | MESSENGER-RNA | INFLAMMATION | SMOOTH-MUSCLE-CELLS | ESSENTIAL-HYPERTENSION | CHRONIC KIDNEY-DISEASE | EXPRESSION | BLOCKER | Adenoviridae | Genetic Vectors - administration & dosage | Myofibroblasts - physiology | Humans | Male | MicroRNAs - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Osteopontin - pharmacology | Female | Osteopontin - physiology | Fibrosis - genetics | Cell Survival | Cells, Cultured | Gene Silencing | PTEN Phosphohydrolase - metabolism | Myocardium - pathology | Recombinant Proteins - pharmacology | Mice, Knockout | Collagen - metabolism | Animals | Aged | MicroRNAs - genetics | Transcription Factors | In Vitro Techniques | Angiotensin II - physiology | Basic Science
Osteopontin | Cardiac fibrosis | microRNA | miR-21 | Angiotensin II | CARDIAC & CARDIOVASCULAR SYSTEMS | MECHANISM | HEART-FAILURE | PROMATRIX METALLOPROTEINASE-9 ACTIVATION | MESSENGER-RNA | INFLAMMATION | SMOOTH-MUSCLE-CELLS | ESSENTIAL-HYPERTENSION | CHRONIC KIDNEY-DISEASE | EXPRESSION | BLOCKER | Adenoviridae | Genetic Vectors - administration & dosage | Myofibroblasts - physiology | Humans | Male | MicroRNAs - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Osteopontin - pharmacology | Female | Osteopontin - physiology | Fibrosis - genetics | Cell Survival | Cells, Cultured | Gene Silencing | PTEN Phosphohydrolase - metabolism | Myocardium - pathology | Recombinant Proteins - pharmacology | Mice, Knockout | Collagen - metabolism | Animals | Aged | MicroRNAs - genetics | Transcription Factors | In Vitro Techniques | Angiotensin II - physiology | Basic Science
Journal Article